Panobinostat set for approval in Europe as multiple myeloma treatment The multiple myeloma drug panobinostat has received a positive opinion from the European Medicines Agency for the treatment of relapsed or refractory disease.…
Low molecular weight heparins for treating venous thromboembolism How to start patients on these common injected anticoagulants and optimise treatment.…
Iron deficiency anaemia: basic management Test your knowledge with this case study on a common condition with non-specific symptoms.…
Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…
Googling the bloodstream: how disease might be detected with ingested nanoparticles Google is developing technology that combines ingested disease-detecting nanoparticles with a wrist sensor.…
Lymphomas: current and future treatment options The management of lymphomas involves a range of different chemotherapy schedules, with novel medicines emerging and offering better treatment options.…
Lymphomas: pathogenesis, clinical features and diagnosis Lymphomas are some of the most common cancers in the UK, with a wide variation in disease progression and prognosis between subtypes.…
GSK’s malaria vaccine shows 45% efficacy in children An ongoing phase III study in Africa indicates that vaccination of children and young infants with RTS,S/AS01 prevented many cases of clinical and severe malaria.…
How filgrastim has helped control neutropenia and prevent sepsisHow the granulocyte colony-stimulating factor filgrastim has become part of the staple diet of chemotherapy…
Thalassaemia and iron supplements Q. I’m pregnant and want to take a vitamin supplement. I know I need folic acid. This product [Pregnacare] also contains iron. I have thalassaemia. Am I right in thinking I shouldn’t take it?…
